title: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired immune-mediated disorder characterized by weakness and sensory deficits that can lead to significant neurological disability. The diagnosis is based on a combination of clinical examination findings, electrodiagnostic studies, and other supportive evidence. Recognizing CIDP and distinguishing it from other chronic polyneuropathies is important because many patients with CIDP are highly responsive to treatment with immunosuppressive or immunomodulatory therapies. This review summarizes the clinical features, diagnosis, and current treatment strategies for CIDP. [Full article available at http://rimed.org/rimedicaljournal-2016-12.asp].
authors.affiliation: Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI.
authors.forename: Jacques
authors.initials: J
authors.lastname: Reynolds
authors.affiliation: Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI.
authors.forename: George
authors.initials: G
authors.lastname: Sachs
authors.affiliation: Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI.
authors.forename: Kara
authors.initials: K
authors.lastname: Stavros
mesh_terms: D006801:Humans; D056747:Immunomodulation; D007165:Immunosuppression Therapy; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis* / Q000628:therapy*
keywords: CIDP; chronic inflammatory demyelinating polyradiculoneuropathy; immune-mediated neuropathy; polyneuropathy